Lachmann H - Search Results

1

Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis.

Porcari A, Masi A, Martinez-Naharro A, Razvi Y, Patel R, Ioannou A, Rauf MU, Sinigiani G, Wisniowski B, Filisetti S, Currie-Cathey J, O'Beara S, Kotecha T, Knight D, Moon JC, Sinagra G, Virsinskaite R, Gilbertson J, Venneri L, Petrie A, Lachmann H, Whelan C, Kellman P, Ravichandran S, Cohen O, Mahmood S, Manisty C, Hawkins PN, Gillmore JD, Wechalekar AD, Fontana M. Porcari A, et al. Among authors: lachmann h. JAMA Cardiol. 2024 Nov 1;9(11):982-989. doi: 10.1001/jamacardio.2024.2555. JAMA Cardiol. 2024. PMID: 39167388 Free PMC article.

2

Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis.

Harrison CJ, Mazzullo H, Ross FM, Cheung KL, Gerrard G, Harewood L, Mehta A, Lachmann HJ, Hawkins PN, Orchard KH. Harrison CJ, et al. Among authors: lachmann hj. Br J Haematol. 2002 May;117(2):427-35. doi: 10.1046/j.1365-2141.2002.03438.x. Br J Haematol. 2002. PMID: 11972529 Free article.

3

Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis.

Lachmann HJ, Booth DR, Booth SE, Bybee A, Gilbertson JA, Gillmore JD, Pepys MB, Hawkins PN. Lachmann HJ, et al. N Engl J Med. 2002 Jun 6;346(23):1786-91. doi: 10.1056/NEJMoa013354. N Engl J Med. 2002. PMID: 12050338 Free article.

4

Interleukin-1-receptor antagonist in the Muckle-Wells syndrome.

Hawkins PN, Lachmann HJ, McDermott MF. Hawkins PN, et al. N Engl J Med. 2003 Jun 19;348(25):2583-4. doi: 10.1056/NEJM200306193482523. N Engl J Med. 2003. PMID: 12815153 Free article. No abstract available.

5

Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy.

Lachmann HJ, Gallimore R, Gillmore JD, Carr-Smith HD, Bradwell AR, Pepys MB, Hawkins PN. Lachmann HJ, et al. Br J Haematol. 2003 Jul;122(1):78-84. doi: 10.1046/j.1365-2141.2003.04433.x. Br J Haematol. 2003. PMID: 12823348 Free article.

6

Novel pharmacological strategies in amyloidosis.

Lachmann HJ, Hawkins PN. Lachmann HJ, et al. Nephron Clin Pract. 2003;94(4):c85-8. doi: 10.1159/000072490. Nephron Clin Pract. 2003. PMID: 12972717 Review.

7

Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra.

Hawkins PN, Lachmann HJ, Aganna E, McDermott MF. Hawkins PN, et al. Arthritis Rheum. 2004 Feb;50(2):607-12. doi: 10.1002/art.20033. Arthritis Rheum. 2004. PMID: 14872505 Free article.

8

Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis.

Gillmore JD, Goodman HJ, Lachmann HJ, Offer M, Wechalekar AD, Joshi J, Pepys MB, Hawkins PN. Gillmore JD, et al. Blood. 2006 Feb 1;107(3):1227-9. doi: 10.1182/blood-2005-08-3253. Epub 2005 Oct 6. Blood. 2006. PMID: 16210334 Free article.

9

Systemic amyloidosis.

Lachmann HJ, Hawkins PN. Lachmann HJ, et al. Curr Opin Pharmacol. 2006 Apr;6(2):214-20. doi: 10.1016/j.coph.2005.10.005. Epub 2006 Feb 17. Curr Opin Pharmacol. 2006. PMID: 16483845 Review.

10

AA amyloidosis complicating hyperimmunoglobulinemia D with periodic fever syndrome: a report of two cases.

Lachmann HJ, Goodman HJ, Andrews PA, Gallagher H, Marsh J, Breuer S, Rowczenio DM, Bybee A, Hawkins PN. Lachmann HJ, et al. Arthritis Rheum. 2006 Jun;54(6):2010-4. doi: 10.1002/art.21901. Arthritis Rheum. 2006. PMID: 16732551 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters